EVOME MEDICAL TECHNOLOGIES INC. Annual Operating Income (Loss) in CAD from 2020 to 2023

Taxonomy & unit
us-gaap: CAD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Evome Medical Technologies Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • Evome Medical Technologies Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -CA$1.32M, a 144% decline year-over-year.
  • Evome Medical Technologies Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -CA$5.52M, a 339% decline year-over-year.
  • Evome Medical Technologies Inc. annual Operating Income (Loss) for 2023 was -CA$5.52M.
  • Evome Medical Technologies Inc. annual Operating Income (Loss) for 2021 was -CA$608K, a 40.6% increase from 2020.
Operating Income (Loss), Trailing 12 Months (CAD)
Operating Income (Loss), Annual (CAD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -5.52M Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2021 -608K +416K +40.6% Mar 1, 2021 Feb 28, 2022 10-KT 2023-04-03
2020 -1.02M Mar 1, 2020 Feb 28, 2021 10-K 2022-05-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.